Form 8-K - Current report:
SEC Accession No. 0001558370-25-006512
Filing Date
2025-05-06
Accepted
2025-05-06 16:30:10
Documents
13
Period of Report
2025-04-30
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K tech-20250430x8k.htm   iXBRL 8-K 39732
  Complete submission text file 0001558370-25-006512.txt   157807

Data Files

Seq Description Document Type Size
2 EX-101.SCH tech-20250430.xsd EX-101.SCH 3397
3 EX-101.LAB tech-20250430_lab.xml EX-101.LAB 15266
4 EX-101.PRE tech-20250430_pre.xml EX-101.PRE 10905
15 EXTRACTED XBRL INSTANCE DOCUMENT tech-20250430x8k_htm.xml XML 4647
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 25917724
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)